Post-transplant native pneumonectomy for interstitial fibrosis and small cell lung cancer

Ramon T. Li, Sanam Zahedi, Judy Trieu, Alfred Lea, William Calhoun, Alexander Duarte, Jianping Zhao, Ikenna Okereke

Research output: Contribution to journalArticle


Lung transplantation is a definitive treatment for select patients with end-stage pulmonary disease. Following transplantation, the reported rate of lung cancer is between 1-9% and is associated with a variety of risk factors, including smoking history and chronic immunosuppression. The majority of posttransplant lung cancer reported in the literature is histologically classified as non-small cell lung carcinoma (NSCLC). We report a unique case of early stage small cell lung carcinoma (SCLC) identified in the native lung following single lung transplantation.

Original languageEnglish (US)
Pages (from-to)E1096-E1099
JournalJournal of Thoracic Disease
Issue number12
StatePublished - Dec 1 2017



  • Lung transplant
  • Pneumonectomy
  • Small cell lung carcinoma (SCLC)

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this